Future AL amyloidosis treatment
The treatment of AL amyloidosis is moving forward with new drugs and aims of treatment. Dr Ashutosh Wechalekar explains the ways in which AL amyloidosis treatment is advancing and how AL amyloidosis patients can accelerate the development of new drugs by taking part in clinical trials.
Browse library content
Stay in touch
We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.
